Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.637 EUR | +1.28% | +7.83% | -22.94% |
Mar. 26 | Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate | MT |
Mar. 26 | Valneva: Phase 1 trial initiated in the Zika virus | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.94% | 545M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |
- Stock
- Equities
- Stock Valneva - Euronext Paris
- News Valneva
- Valneva : Ends Liquidity Deal With Oddo BHF, Natixis